XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
ORDINARY SHARE AND SHARE INCENTIVE PLANS (Tables)
12 Months Ended
Dec. 31, 2023
Summary of the Assumptions Used in the Estimating the Fair Values of Stock-based Payment Awards Excluding Non-employee

 

 

Years ended December 31,

 

Stock Options:

 

2023

 

 

2016

 

Expected term in years

 

 

4.25

 

 

 

4.75

 

Weighted average risk-free interest rate

 

 

1.02

%

 

 

1.30

%

Expected dividend rate

 

 

%

 

 

%

Volatility

 

 

55.21

%

 

 

51.6

%

Summary of Stock-based Compensation Expense Recognized in Consolidated Statements of Comprehensive Loss

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Cost of net sales

 

$

28

 

 

$

97

 

 

$

87

 

Selling, general and administrative

 

 

151

 

 

 

258

 

 

 

236

 

Research and development

 

 

114

 

 

 

248

 

 

 

181

 

Total

 

$

293

 

 

$

603

 

 

$

504

 

2017 Equity Incentive Plan  
Summary of Stock Options Activity

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

average

 

 

 

shares

 

 

exercise

 

 

 

outstanding

 

 

price

 

 

 

(in thousands)

 

 

 

 

Options Outstanding, December 31, 2021

 

 

364

 

 

$

4.47

 

Options granted

 

 

 

 

 

 

Options exercised

 

 

(4

)

 

 

4.52

 

Options forfeited or expired

 

 

(13

)

 

 

6.59

 

Options Outstanding, December 31, 2022

 

 

347

 

 

$

4.39

 

Options granted

 

 

 

 

 

 

Options exercised

 

 

(1

)

 

 

4.28

 

Options cancelled

 

 

(8

)

 

 

4.45

 

Options forfeited or expired

 

 

(16

)

 

 

4.44

 

Options Outstanding, December 31, 2023

 

 

322

 

 

$

4.39

 

Summary of Unvested Restricted Awards

 

 

 

 

 

Weighted

 

 

 

 

 

 

average

 

 

 

 

 

 

grant date

 

 

 

Shares

 

 

fair value

 

 

 

(in thousands)

 

 

 

 

Total nonvested restricted stock at December 31, 2021

 

 

59

 

 

$

9.56

 

Granted

 

 

29

 

 

 

3.97

 

Vested

 

 

(44

)

 

 

9.66

 

Forfeited

 

 

(1

)

 

 

14.82

 

Total nonvested restricted stock at December 31, 2022

 

 

43

 

 

$

5.65

 

Granted

 

 

30

 

 

 

3.79

 

Vested

 

 

(38

)

 

 

5.32

 

Forfeited

 

 

 

 

 

 

Total nonvested restricted stock at December 31, 2023

 

 

35

 

 

$

3.28

 

Summary of Significant Ranges of Outstanding and Exercisable Stock Options

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of shares

 

 

Average

 

 

Weighted

 

 

Number of shares

 

 

Weighted

 

Range of

 

 

Outstanding

 

 

Remaining

 

 

Average

 

 

Exercisable

 

 

Average

 

Exercise Prices

 

 

as of 12/31/2023

 

 

Contractual Term

 

 

Exercise Price

 

 

as of 12/31/2023

 

 

Exercise Price

 

$

4.28

 

 

$

4.28

 

 

 

194,777

 

 

4.92

 

 

$

4.28

 

 

 

194,777

 

$

4.28

 

$

4.56

 

 

$

4.56

 

 

 

127,019

 

 

 

3.92

 

 

$

4.56

 

 

 

127,019

 

 

$

4.56

 

 

 

 

 

Number of
shares

 

 

Weighted
average
exercise price

 

Options exercisable as of December 31, 2023

 

 

321,796

 

 

$

4.39

 

Options vested and expected to vest as of December 31, 2023

 

 

321,796

 

 

$

4.39